CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder

Journal of Urology

Volumn 194, Issue 2, 2015, Pages 556-562

  Wang, Bo ^a   Wu, Shaoxu ^a   Zeng, Hong ^a   Liu, Zhuowei ^a   Dong, Wen ^a   He, Wang ^a   Chen, Xu ^a   Dong, Xiaoliang ^a   Zheng, Limin ^b   Lin, Tianxin ^a   Huang, Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

antigens; carcinoma; CD8; lymphocytes; prognosis; tumor infiltrating; urinary bladder

Indexed keywords

CD103 ANTIGEN; CD8 ANTIGEN; UVOMORULIN; ALPHA E INTEGRINS; ALPHA INTEGRIN; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER TISSUE; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CYSTECTOMY; DENSITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR ASSOCIATED LEUKOCYTE; BLADDER; BLADDER TUMOR; CHINA; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, TRANSITIONAL CELL; CHINA; DISEASE-FREE SURVIVAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA CHAINS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84943355716     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.02.2941     Document Type: Article

References (30)

1. B.L. Jacobs, C.T. Lee, and J.E. Montie Bladder cancer in 2010: how far have we come? CA Cancer J Clin 60 2010 244
2. M. Babjuk, M. Burger, R. Zigeuner, and et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013 Eur Urol 64 2013 639
3. D.L. Lamm, B.A. Blumenstein, E.D. Crawford, and et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder N Engl J Med 325 1991 1205
4. D.L. Lamm, B.A. Blumenstein, J.D. Crissman, and et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study J Urol 163 2000 1124
5. T. Powles, J.P. Eder, G.D. Fine, and et al. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer Nature 515 2014 558
6. P. Sharma, Y. Shen, S. Wen, and et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma Proc Natl Acad Sci U S A 104 2007 3967
7. M.M. Mueller, and N.E. Fusenig Friends or foes - bipolar effects of the tumour stroma in cancer Nat Rev Cancer 4 2004 839
8. D. Hanahan, and L.M. Coussens Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 21 2012 309
9. J. Galon, A. Costes, F. Sanchez-Cabo, and et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 2006 1960
10. W.H. Fridman, F. Pages, C. Sautes-Fridman, and et al. The immune contexture in human tumours: impact on clinical outcome Nat Rev Cancer 12 2012 298
11. E. Sato, S.H. Olson, J. Ahn, and et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci U S A 102 2005 18538
12. J. Fu, D. Xu, Z. Liu, and et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology 132 2007 2328
13. W.W. Agace, J.M. Higgins, B. Sadasivan, and et al. T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines Curr Opin Cell Biol 12 2000 563
14. B.S. Sheridan, and L. Lefrançois Regional and mucosal memory T cells Nat Immunol 12 2011 485
15. T. Sathaliyawala, M. Kubota, N. Yudanin, and et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets Immunity 38 2013 187
16. A. Le Floc'h, A. Jalil, I. Vergnon, and et al. Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis J Exp Med 204 2007 559
17. E. Jouanneau, K.L. Black, L. Veiga, and et al. Intrinsically de-sialylated CD103 CD8 T cells mediate beneficial anti-glioma immune responses Cancer Immunol Immunother 63 2014 911
18. J.R. Webb, K. Milne, P.H. Watson, and et al. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer Clin Cancer Res 20 2014 434
19. T.A. Zikos, A.D. Donnenberg, R.J. Landreneau, and et al. Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer Cancer Immunol Immunother 60 2011 819
20. J. Cresswell, H. Robertson, D.E. Neal, and et al. Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas Clin Exp Immunol 126 2001 397
21. J. Liu, M. Cai, J. Chen, and et al. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients Eur J Cancer 50 2014 840
22. B. Wang, L. Li, Y. Liao, and et al. Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma Cancer Immunol Immunother 62 2013 1575
23. T. Ding, J. Xu, Y. Zhang, and et al. Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection Cancer 117 2011 4878
24. K. Kashibuchi, K. Tomita, J.A. Schalken, and et al. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract Eur Urol 49 2006 839
25. I.P. Witz, and O. Levy-Nissenbaum The tumor microenvironment in the post-PAGET era Cancer Lett 242 2006 1
26. H. Angell, and J. Galon From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer Curr Opin Immunol 25 2013 261
27. J. Galon, F. Pages, F.M. Marincola, and et al. Cancer classification using the Immunoscore: a worldwide task force J Transl Med 10 2012 205
28. E.A. Morgan, H. Yu, J.L. Pinkus, and et al. Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody Am J Clin Pathol 139 2013 220
29. J. Gao, C. Bernatchez, P. Sharma, and et al. Advances in the development of cancer immunotherapies Trends Immunol 34 2013 90
30. J.J. French, J. Cresswell, W.K. Wong, and et al. T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy? Br J Cancer 87 2002 1034